Vascular Smooth Muscle Cell Dynamics in Restenosis

Restenosis following angioplasty or stent deployment remains a major clinical challenge due to the proliferative and migratory response of vascular smooth muscle cells (VSMCs). In response to endothelial injury, VSMCs undergo phenotypic switching from a quiescent, contractile state to a synthetic state characterised by enhanced proliferation, migration and extracellular matrix synthesis. This leads to neointimal hyperplasia and vessel re-narrowing. Multiple stimuli—including growth factors, inflammatory cytokines, mechanical stress and metabolic derangements—converge on intracellular pathways that regulate cell cycle progression, cytoskeletal remodelling and survival. Crosstalk between macrophages and VSMCs via Notch ligands and toll-like receptor signalling further amplifies neointimal formation. Endoplasmic reticulum stress and redox imbalance are increasingly recognised as modulators of VSMC behaviour, offering new therapeutic angles. Advances in biomaterials and drug delivery aim to suppress aberrant VSMC activity while preserving endothelial repair, thereby restoring vessel patency and reducing the global burden of cardiovascular disease.

Research from Nature Portfolio

Recent studies have elucidated how metabolic stress in diabetes can exacerbate VSMC dysfunction. Elevated palmitic acid levels activate macrophage Delta-like ligand 4 signalling, driving VSMC senescence and collagen depletion within atherosclerotic plaques, thereby increasing vulnerability to restenosis even under glucose-lowering regimens. Separately, foundational work on endoplasmic reticulum stress demonstrated that maladaptive activation of the unfolded protein response in VSMCs following vascular injury accelerates neointimal thickening. Pharmacological reduction of ER stress attenuates proliferation and migration of injured VSMCs, highlighting the UPR as a suppressive checkpoint in post-angioplasty restenosis.

Vascular Smooth Muscle Cell Dynamics in Restenosis publication trend

The graph below shows the total number of articles in vascular smooth muscle cell dynamics in restenosis across all publications each year (not limited to Nature Index journals).

Technical terms

Neointimal hyperplasia: Pathological thickening of the vessel intima due to VSMC proliferation and extracellular matrix deposition.

Phenotypic switching: Transition of VSMCs from a contractile to a synthetic state, marked by altered gene expression and behaviour.

Endoplasmic reticulum (ER) stress: Cellular condition arising from accumulation of misfolded proteins in the ER lumen.

Unfolded protein response (UPR): Adaptive signalling cascade activated by ER stress that regulates protein folding and cell fate.

Delta-like ligand 4 (Dll4): A Notch receptor ligand expressed by macrophages that influences VSMC senescence and phenotype.

Hydrogel: A water-rich polymer network used as a scaffold for controlled delivery of therapeutic agents.

Redox stress: Imbalance between reactive oxygen species production and antioxidant defences, affecting cellular signalling.

References

1. Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling. Nature Communications (2024).
2. An Integrated Arterial Remodeling Hydrogel for Preventing Restenosis After Angioplasty. Advanced Science (2024).
3. The Mechanisms of Restenosis and Relevance to Next Generation Stent Design. Biomolecules (2022).
4. Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated‐M1 Macrophage Polarization‐Dependent Vascular Smooth Muscle Cell Phenotypic Conversion. Oxidative Medicine and Cellular Longevity (2022).
5. Reduction of endoplasmic reticulum stress inhibits neointima formation after vascular injury. Scientific Reports (2014).